Rhonda L. Bohn

4.5k total citations · 1 hit paper
83 papers, 3.5k citations indexed

About

Rhonda L. Bohn is a scholar working on Hematology, Cardiology and Cardiovascular Medicine and Immunology. According to data from OpenAlex, Rhonda L. Bohn has authored 83 papers receiving a total of 3.5k indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Hematology, 12 papers in Cardiology and Cardiovascular Medicine and 11 papers in Immunology. Recurrent topics in Rhonda L. Bohn's work include Hemophilia Treatment and Research (12 papers), Psoriasis: Treatment and Pathogenesis (7 papers) and Autoimmune Bullous Skin Diseases (6 papers). Rhonda L. Bohn is often cited by papers focused on Hemophilia Treatment and Research (12 papers), Psoriasis: Treatment and Pathogenesis (7 papers) and Autoimmune Bullous Skin Diseases (6 papers). Rhonda L. Bohn collaborates with scholars based in United States, Germany and Canada. Rhonda L. Bohn's co-authors include Jerry Avorn, Helen Mogun, Mark Monane, Robert J. Glynn, Jerry H. Gurwitz, Johanne Monette, Jacques LeLorier, Philip S. Wang, Eric L. Knight and Robert J. Glynn and has published in prestigious journals such as JAMA, Blood and Journal of the American College of Cardiology.

In The Last Decade

Rhonda L. Bohn

81 papers receiving 3.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Persistence of Use of Lipid-Lowering Medications

1998 548 citations Jerry Avorn, Johanne Monette et al. profile →

Peers

Countries citing papers authored by Rhonda L. Bohn

Since Specialization

Citations

This map shows the geographic impact of Rhonda L. Bohn's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rhonda L. Bohn with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rhonda L. Bohn more than expected).

Fields of papers citing papers by Rhonda L. Bohn

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rhonda L. Bohn. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rhonda L. Bohn. The network helps show where Rhonda L. Bohn may publish in the future.

Co-authorship network of co-authors of Rhonda L. Bohn

This figure shows the co-authorship network connecting the top 25 collaborators of Rhonda L. Bohn. A scholar is included among the top collaborators of Rhonda L. Bohn based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rhonda L. Bohn. Rhonda L. Bohn is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Effect of glucagon-like peptide-1 receptor agonists on vascular risk factors among adults with type 2 diabetes and established atherosclerotic cardiovascular disease 2025 ·American Journal of Preventive Cardiology ·Aaron A. King, Xi Tan, Neil Dhopeshwarkar, Rhonda L. Bohn, Katherine Dea, Charles E. Leonard, Adam de Havenon	2
2	Varied treatment patterns among patients with palmoplantar pustulosis: A claims-based cohort study using data from 2 large US databases 2024 ·JAAD International ·Jashin J. Wu, (unknown), Rhonda L. Bohn, Anouk Déruaz‐Luyet, (unknown), Frank Baehner, Steven R. Feldman	1
3	Poor adherence to and persistence with biologics in generalized pustular psoriasis: A claim-based study using real-world data from two large US databases 2024 ·JAAD International ·Steven R. Feldman, Rhonda L. Bohn, (unknown), (unknown), (unknown), Anouk Déruaz‐Luyet, Jashin J. Wu	1
4	Incidence of RSV in Adults: A Comprehensive Review of Observational Studies and Critical Gaps in Information 2024 ·The Journal of Infectious Diseases ·(unknown), Parinaz Ghaswalla, Rhonda L. Bohn, Sonia Stoszek, Catherine A. Panozzo	8
5	Challenges associated with access to recently developed hemophilia treatments in routine care: perspectives of healthcare professionals 2024 ·Haematologica ·Karin Berger, (unknown), Matteo Nicola Dario Di Minno, Angelika Bátorová, Kaan Kavaklı, Pier Mannuccio Mannucci, Wolfgang Schramm, Rhonda L. Bohn, Louis M. Aledort	1
6	Recent trends in GLP-1 RA and SGLT2i use among people with type 2 diabetes and atherosclerotic cardiovascular disease in the USA 2024 ·BMJ Open Diabetes Research & Care ·Aaron A. King, Xi Tan, Neil Dhopeshwarkar, Rhonda L. Bohn, Katherine Dea, Charles E. Leonard, Adam de Havenon	14
7	Outcomes Associated with Dronedarone Use in Patients with Atrial Fibrillation 2020 ·The American Journal of Cardiology ·Earl Goehring, Rhonda L. Bohn, John C. Pezzullo, (unknown), Judith K. Jones, (unknown), (unknown), Nicholas Sicignano, Gerald V. Naccarelli	8
8	Clinical outcomes following bone marrow transplantation in patients with sickle cell disease: A cohort study of US Medicaid enrollees 2020 ·European Journal Of Haematology ·Mufaddal Mahesri, Sebastian Schneeweiß, Denise Globe, Alex Mutebi, Rhonda L. Bohn, Maureen Achebe, Raisa Levin, Rishi Desai	7
9	PRS25 HEALTHCARE RESOURCE UTILIZATION AND RELATED COSTS IN PROGRESSIVE FIBROSING INTERSTITIAL LUNG DISEASES (ILDS) 2020 ·Value in Health ·Amy L. Olson, N Hartmann, Padmaja Patnaik, Elizabeth M. Garry, Rhonda L. Bohn, David Singer, Michael Baldwin, Laura Wallace	2
10	Clinical outcomes and healthcare utilization in patients with sickle cell disease: a nationwide cohort study of Medicaid beneficiaries 2020 ·Annals of Hematology ·Rishi Desai, Mufaddal Mahesri, Denise Globe, Alex Mutebi, Rhonda L. Bohn, Maureen Achebe, Raisa Levin, Sebastian Schneeweiß	18
11	Use of Bypassing Agents and Risk of Thromboembolic Events in Patients with Haemophilia and Inhibitors 2017 ·Thrombosis and Haemostasis ·Katsiaryna Bykov, Rhonda L. Bohn, Bruce M. Ewenstein, John D. Seeger, Jerry Avorn, Brian T. Bateman	6
12	REAL-WORLD OUTCOMES FOR DRONEDARONE INITIATORS COMPARED TO OTHER ANTIARRHYTHMIC AGENTS IN THE TREATMENT OF ATRIAL FIBRILLATION IN A LARGE UNITED STATES POPULATION 2013 ·Journal of the American College of Cardiology ·Earl Goehring, Rhonda L. Bohn, John C. Pezzullo, Judith A. Jones	1
13	Early Steps in the Development of a Claims-Based Targeted Healthcare Safety Monitoring System and Application to Three Empirical Examples 2012 ·Drug Safety ·Peter Wahl, Joshua J. Gagne, Thomas Wasser, D. Eisenberg, (unknown), Gregory W. Daniel, Marcus D. Wilson, Sebastian Schneeweiß, Jeremy A. Rassen, Amanda R. Patrick, Jerry Avorn, Rhonda L. Bohn	11
14	The economic impact of factor VIII inhibitors in patients with haemophilia 2004 ·Haemophilia ·Rhonda L. Bohn, Louis M. Aledort, (unknown), Bruce M. Ewenstein, Helen Mogun, Jerry Avorn	49
15	Delayed nephrologist referral and inadequate vascular access in patients with advanced chronic kidney failure 2002 ·Journal of Clinical Epidemiology ·Jerry Avorn, Wolfgang C. Winkelmayer, Rhonda L. Bohn, Raisa Levin, Robert J. Glynn, Elliot Levy, William F. Owen	127
16	Nephrologist Care and Mortality in Patients With Chronic Renal Insufficiency 2002 ·Archives of Internal Medicine ·Jerry Avorn, Rhonda L. Bohn, Elliott Levy, Raisa Levin, William F. Owen, Wolfgang C. Winkelmayer, Robert J. Glynn	123
17	Zolpidem Use and Hip Fractures in Older People 2001 ·Journal of the American Geriatrics Society ·(unknown), Rhonda L. Bohn, Robert J. Glynn, Helen Mogun, Jerry Avorn	188
18	Concurrent Use of Antiulcerative Agents 1997 ·Journal of Clinical Gastroenterology ·Johanne Monette, Helen Mogun, Rhonda L. Bohn, Jerry Avorn	2
19	Thiazide diuretics and the initiation of anti-gout therapy 1997 ·Journal of Clinical Epidemiology ·Jerry H. Gurwitz, (unknown), Rhonda L. Bohn, Robert J. Glynn, Mark Monane, Helen Mogun, Jerry Avorn	73
20	Old Age and Race as Determinants of Initiation of Glaucoma Therapy 1993 ·American Journal of Epidemiology ·Robert J. Glynn, Jerry H. Gurwitz, Rhonda L. Bohn, Mark Monane, Igor Choodnovskiy, Jerry Avorn	22

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact